Skip to main content
. 2021 Jan 2;100(2):465–479. doi: 10.1007/s00277-020-04387-7

Fig. 4.

Fig. 4

Forest plot of the pooled HRs and 95% CIs for OS in PMF patients with ASXL1 mutations (after removed the studies of Guglielmelli 2017 * and Tefferi 2018 ##) by a fixed-effects model. Number sign, one cohort of the study; single asterisk, another cohort of the study; double number sign, British Journal of Haematology; double asterisk, Leukemia